[The antiarrhythmic effect of intravenous 17-monochloroacetyl-ajmaline. A review of 50 treated cases].
D000404:Ajmaline / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D004341:Drug Evaluation; D006801:Humans
D000889:Anti-Arrhythmia Agents; D000404:Ajmaline; C008541:17-monochloroacetylajmaline
Efectividad antiarrítmica de la 17-monocloroacetilajmalina por vía intravenosa. Revisión a propósito de 50 casos tratados.